(XENE) Xenon Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xenon Pharmaceuticals | (XENE) share price targets
Complete technical analysis of Xenon Pharmaceuticals (XENE) by charts plus indicators, forecast predictions and share price targets for Xenon Pharmaceuticals (XENE)
Xenon Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-03 View latest technical analysis
10 day averaged volume of Xenon Pharmaceuticals is 431410
Date | Daily Closing Price | Open | High | Low | Volume |
03 Fri Jan 2025 | 40.51 | 40.18 | 41.58 | 40.18 | 0.751 times |
02 Thu Jan 2025 | 40.17 | 39.39 | 42.23 | 39.39 | 1.266 times |
31 Tue Dec 2024 | 39.20 | 38.82 | 39.28 | 38.35 | 1 times |
30 Mon Dec 2024 | 38.53 | 38.38 | 39.00 | 38.03 | 0.691 times |
27 Fri Dec 2024 | 38.83 | 39.19 | 39.53 | 38.41 | 0.627 times |
26 Thu Dec 2024 | 39.48 | 38.21 | 39.49 | 38.12 | 0.56 times |
24 Tue Dec 2024 | 38.42 | 38.30 | 38.76 | 37.61 | 0.3 times |
23 Mon Dec 2024 | 38.14 | 38.61 | 38.72 | 37.91 | 0.831 times |
20 Fri Dec 2024 | 38.63 | 38.93 | 39.46 | 38.00 | 2.444 times |
19 Thu Dec 2024 | 38.99 | 39.43 | 39.57 | 37.52 | 1.177 times |
My analysis of stock is bullish for shortterm, and stock might move up till 41.7 or till 43.5. Use a stoploss of 40.2 and if this stock hits its stoploss, then it can fall down till 38.7
Share price targets for Xenon Pharmaceuticals (XENE)
Target Type | Value |
Downside Target | 37.34 |
Downside Target | 38.95 |
Upside Target | 41.62 |
Upside Target | 41.72 |
Upside Target | 42.23 |
Upside Target | 42.75 |
Upside Target | 43.38 |
Upside Target | 45.52 |
Upside Target | 46.00 |
Intraday share price targets for Xenon Pharmaceuticals (XENE)
Target Type | Value |
Downside Intraday Target | 38.28 |
Downside Intraday Target | 36.06 |
Upside Intraday Target | 42.48 |
Upside Intraday Target | 44.46 |
Downside Intraday Target | 40.26 |
Weekly technical analysis of Xenon Pharmaceuticals (XENE)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Fri Jan 2025 | 40.51 | 38.38 | 42.23 | 38.03 | 1.6 times |
27 Fri Dec 2024 | 38.83 | 38.61 | 39.53 | 37.61 | 0.367 times |
20 Fri Dec 2024 | 38.63 | 40.01 | 41.62 | 37.52 | 1.621 times |
13 Fri Dec 2024 | 40.05 | 42.73 | 43.38 | 38.95 | 3.477 times |
26 Tue Nov 2024 | 42.45 | 41.70 | 42.75 | 41.69 | 0.5 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Xenon Pharmaceuticals (XENE)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Fri Jan 2025 | 40.51 | 39.39 | 42.23 | 39.39 | 0.142 times |
31 Tue Dec 2024 | 39.20 | 42.73 | 43.38 | 37.52 | 0.753 times |
26 Tue Nov 2024 | 42.45 | 41.46 | 46.00 | 37.34 | 0.954 times |
31 Thu Oct 2024 | 41.11 | 40.50 | 45.52 | 39.23 | 1.36 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xenon Pharmaceuticals (XENE)
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xenon Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xenon Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xenon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xenon Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xenon Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 39.09 and Xenon Pharmaceuticals (XENE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xenon Pharmaceuticals (XENE) stock. Volume based technical analysis of Xenon Pharmaceuticals (XENE) stock is negative.
Xenon Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xenon Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xenon Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xenon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xenon Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xenon Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 39.09 and Xenon Pharmaceuticals (XENE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xenon Pharmaceuticals (XENE) stock. Volume based technical analysis of Xenon Pharmaceuticals (XENE) stock is negative.
Xenon Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.